gd_老虎社区_美港股上老虎

choya
2021-08-05

Moderna gained over 2% and reached record high

(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff

Moderna gained over 2% and reached record high

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":899876927,"tweetId":"899876927","gmtCreate":1628175758169,"gmtModify":1633752898100,"author":{"id":3585264987238241,"idStr":"3585264987238241","authorId":3585264987238241,"authorIdStr":"3585264987238241","name":"choya","avatar":"https://static.tigerbbs.com/bf32f96fd67870273541927f4a6ed9e6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>gd</p></body></html>","htmlText":"<html><head></head><body><p>gd</p></body></html>","text":"gd","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/899876927","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug&nbsp;5)&nbsp;Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":165,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}